WASHINGTON, Jan 18 (Reuters) - Mallinckrodt Plc,
which bought Questcor Pharmaceuticals in 2014, has agreed to pay
$100 million to settle allegations that Questcor broke antitrust
law in pricing its multiple sclerosis drug H.P. Acthar Gel, the
Federal Trade Commission said on Wednesday.
(Reporting by Diane Bartz; Editing by Sandra Maler)
Read more
No comments:
Post a Comment